The short answer: A small drop in eGFR after starting certain blood pressure medicines can be an expected effect rather than permanent kidney damage. This is especially true with ACE inhibitors and ARBs, which change pressure inside the kidney’s filtering units. However, a substantial or continuing decline in kidney function needs evaluation, particularly if creatinine rises significantly, potassium increases, blood pressure becomes too low, or dehydration or another kidney problem is present.
Why can eGFR fall after starting a blood pressure medicine?
eGFR is an estimate of how well your kidneys filter blood. It is usually calculated from your blood creatinine level.
ACE inhibitors, such as lisinopril, and ARBs, such as losartan, reduce the effects of angiotensin II. One consequence is relaxation of the blood vessel leaving the kidney’s filtering unit. This lowers pressure inside the filter.
That change can cause a modest rise in creatinine and corresponding fall in eGFR. It does not necessarily mean the medicine is damaging kidney tissue. In fact, ACE inhibitors and ARBs can slow CKD progression and reduce albuminuria in appropriate patients.
What amount of change is usually concerning?
Clinicians commonly use the change in serum creatinine rather than the percentage change in eGFR alone when assessing the early response to an ACE inhibitor or ARB.
KDIGO guidance states that an increase in creatinine of more than 30% from baseline within about 4 weeks after starting or increasing an ACE inhibitor or ARB should prompt clinical assessment. A rise below this level does not automatically require stopping the medicine when there are no other complications.
This is a guide, not a guarantee of safety. The significance of a change depends on the person’s baseline kidney function, potassium level, blood pressure, fluid status, other medicines, and the reason for treatment.
For example, an eGFR falling from 60 to 55 is not interpreted the same way as a rapid fall from 60 to 35.
When might the drop be more concerning?
A larger or unexpected decline deserves closer evaluation, especially when it occurs with:
- A creatinine increase of more than about 30% after starting or increasing an ACE inhibitor or ARB
- High potassium
- Very low blood pressure or dizziness from low blood pressure
- Dehydration, vomiting, or diarrhea
- Reduced urine output
- Recent use of NSAID pain medicines
- Another acute illness
- A continuing decline rather than stabilization
These situations can point to reduced kidney blood flow, medication-related complications, or acute kidney injury (AKI) rather than a simple expected medication effect.
Timing matters
After starting or increasing an ACE inhibitor or ARB, changes in creatinine often occur relatively early. KDIGO recommends checking blood pressure, serum creatinine, and potassium within 2–4 weeks, with earlier testing for people at higher risk of complications.
A result should therefore be compared with the baseline creatinine and eGFR before treatment, rather than viewed in isolation.
The pattern matters:
Baseline → medication started → early creatinine/eGFR change → repeat testing → stabilization or continued decline
A small early change that stabilizes is different from a rapidly worsening result.
What about other blood pressure medicines?
Not every blood pressure medicine causes the same kidney-related change.
Diuretics, for example, can reduce excess fluid. If they contribute to excessive fluid loss or dehydration, kidney function can worsen. Other blood pressure medicines have different effects and risks.
Therefore, simply seeing a lower eGFR after starting “a blood pressure medicine” does not identify the cause. The specific medication, dose change, blood pressure, hydration status, and other medicines all matter.
Should you stop the medication?
Do not stop or change a prescribed blood pressure medicine on your own because your eGFR has fallen.
Some medications that cause an early change in kidney blood tests can also provide important cardiovascular or kidney benefits. ACE inhibitors and ARBs, for example, may slow CKD progression, particularly in people with albuminuria.
Instead, contact the clinician who prescribed the medication and ask whether your creatinine, potassium, blood pressure, and fluid status should be rechecked.
If the change is substantial, clinicians may look for reversible contributors such as dehydration, NSAID use, low blood pressure, or other causes of reduced kidney blood flow before deciding how treatment should be adjusted.
When is urgent medical attention needed?
Seek prompt medical assessment if a kidney-function decline occurs with very low urine output, severe weakness, fainting, confusion, severe dehydration, severe shortness of breath, chest symptoms, or other signs of serious illness.
A significantly abnormal potassium result can also require urgent attention, even when the person feels well.
Bottom line
A falling eGFR after starting a blood pressure medicine does not automatically mean kidney damage.
With ACE inhibitors and ARBs, a modest early change in creatinine can be an expected effect of how these medicines alter pressure within the kidney. The key questions are:
How large is the change? When did it happen? Did it stabilize? What happened to potassium and blood pressure? Are dehydration, NSAIDs, or another illness involved?
Comparing the new result with your baseline and repeating the appropriate tests is usually much more informative than judging one eGFR number alone.